Hyperelongated biglycan: the surreptitious initiator of atherosclerosis-Reference-Cited by-同舟云学术

Hyperelongated biglycan: the surreptitious initiator of atherosclerosis

Published:2008-10 Issue:5 Volume:19 Page:448-454
ISSN:0957-9672
Container-title:Current Opinion in Lipidology
language:en
Short-container-title:

Author:

Little Peter J,Osman Narin,O'Brien Kevin D

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Genetics,Molecular Biology,Endocrinology, Diabetes and Metabolism

Reference68 articles.

1. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects: Atherosclerosis Risk in Communities Study;Hozawa;Arch Intern Med,2007

2. Mortality trends in men and women with diabetes, 1971 to 2000;Gregg;Ann Intern Med,2007

3. Cardiovascular morbidity and mortality associated with the metabolic syndrome;Isomaa;Diabetes Care,2001

4. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Rosamond;Circulation,2008

5. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey;Ford;J Am Med Assoc,2002

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review;Atherosclerosis;2024-10

2. Atorvastatin's Therapeutic Potential in Atherosclerosis: Inhibiting TGF-β-Induced Proteoglycan Glycosaminoglycan Chain Elongation through ROS-ERK1/2-Smad2L Signaling Pathway Modulation in Vascular Smooth Muscle Cells;CELL J;2024

3. Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba;Acta Pharmaceutica Sinica B;2024-01

4. Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes;Contemporary Diabetes;2023

5. Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in atherosclerosis;Cellular Signalling;2022-12